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Abstract
Objective: Posthypoxic myoclonus (PHM) in the first few days after resuscita-
tion can be divided clinically into generalized and focal (uni- and multifocal)
subtypes. The former is associated with a subcortical origin and poor prognosis
in patients with postanoxic encephalopathy (PAE), and the latter with a cortical
origin and better prognosis. However, use of PHM as prognosticator in PAE is
hampered by the modest objectivity in its clinical assessment. Therefore, we
aimed to obtain the anatomical origin of PHM with use of neurophysiological
investigations, and relate these to its clinical presentation. Methods: This study
included 20 patients (56  18 y/o, 68% M, 2 survived, 1 excluded) with EEG-
EMG-video recording. Three neurologists classified PHM into generalized or
focal PHM. Anatomical origin (cortical/subcortical) was assessed with basic and
advanced neurophysiology (Jerk-Locked Back Averaging, coherence analysis).
Results: Clinically assessed origin of PHM did not match the result obtained
with neurophysiology: cortical PHM was more likely present in generalized than
in focal PHM. In addition, some cases demonstrated co-occurrence of cortical
and subcortical myoclonus. Patients that recovered from PAE had cortical myo-
clonus (1 generalized, 1 focal). Interpretation: Hypoxic damage to variable cor-
tical and subcortical areas in the brain may lead to mixed and varying clinical
manifestations of myoclonus that differ of those patients with myoclonus gener-
ally encountered in the outpatient clinic. The current clinical classification of
PHM is not adequately refined to play a pivotal role in guiding treatment deci-
sions to withdraw care. Our neurophysiological characterization of PHM pro-
vides specific parameters to be used in designing future comprehensive studies
addressing the potential role of PHM as prognosticator in PAE.
Introduction
Myoclonus in the first few days after hypoxic brain dam-
age is in general considered to predict an unfavorable
prognosis in patients who remain comatose after car-
diopulmonary resuscitation (CPR).1–3 The incidence of
posthypoxic myoclonus (PHM) in resuscitated patients
with postanoxic encephalopathy (PAE) is 19%, and only
9–14% of these patients recover with mild to no cognitive
deficits.4–6
In terms of prognosis, there appears to be a distinction
between focal PHM (unifocal and multifocal) and gener-
alized PHM. The survival of comatose patients with gen-
eralized PHM admitted at an intensive care unit (ICU) is
reported to be poor (3%) in comparison with focal
PHM patients (17%).4,5 Generalized PHM is associated
with a subcortical origin. In this type of PHM the jerks
are generalized and synchronous with predominant
involvement of the proximal musculature.7–11 In contrast,
focal PHM is associated with a primary cortical origin. In
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the latter, more subtle, asynchronous jerks occur predom-
inantly in distal musculature.9–11
Despite recent improvements in the specificity of PAE
prognostication, there is still a need for more sensitive
prognostic parameters in PAE,12,13 and the clinical subtype
of PHM might serve as one. However, one of the challenges
for the use of PHM as prognosticator is that the clinical dis-
tinction between focal and generalized PHM is compli-
cated; the assessment is hampered by the dynamic and
intermittent character of PHM, hypothermia and medica-
tion effects.13–16 In contrast to the current American guide-
line for postanoxic coma, the presence of PHM is not
included as a criterion for poor prognosis in the European
guideline.17 This guideline states that the various clinical
and neurophysiological features of PHM need to be estab-
lished before PHM can be reliably used for prognostica-
tion.17 The rationale is that in order to prevent incorrect
treatment decisions (false positives), it is important to
obtain more quantitative measurements on the different
clinical manifestations of PHM pathophysiology.
In myoclonus patients, EEG-EMG investigations can
help to differentiate between a cortical (CM) and subcor-
tical (SM) origin of myoclonus.11 The first step in analyz-
ing the origin of PHM is the visual analysis of EEG in
relation to the myoclonic jerks. EEG spike discharges pre-
ceding myoclonic jerks are a sign of CM.10 In addition to
EEG, burst duration on EMG can discriminate as CM is
typically below 75 msec, whereas SM is more likely to
have a longer burst duration.9 Furthermore, in polymyo-
graphic EMG the pattern of muscle activation during a
myoclonic jerk is different between CM and SM. In SM,
muscles innervated by cranial nerves close to the reticular
formation contract first, followed by muscles up- and
downstream from the (caudal) brainstem.11,18,19 A strictly
downstream (i.e., cranio-caudal) muscle recruitment pat-
tern is more likely to originate from the cortex.11 Finally,
a combined EEG-EMG approach permits identifying the
origin of myoclonus by Jerk-Locked Back Averaging
(JLBA) and coherence analysis.11,18,20–23
To proceed in evaluating PHM as potential prognosti-
cator in PAE, and to provide new insights into the patho-
physiology of PHM, we aimed to objectify the
interrelation between the clinical and neurophysiological
manifestations of PHM. For this reason, we conducted




Twenty adult patients with PHM occurring within 5 days
after CPR were consecutively included between February
2009 and November 2014 as part of the usual PHM
work-up in the ICU. In nine patients EEG-EMG record-
ings along with concurrent video recording were assessed
prospectively, and in 11 patients the recordings were
derived from the EEG database of the Department of
Clinical Neurophysiology. The exclusion criteria were: a
Glasgow Coma Score above eight, traumatic brain injury,
epilepsy, history of myoclonus, possible origin of myoclo-
nus other than PAE, and medication overdose. All
patients received target temperature management (target:
32°C n = 13, 36°C n = 6) and were sedated during the
first ~24 h of ICU admission. The etiology and location
of cardiac arrest, first monitored rhythm, time to return
of spontaneous circulation, time to onset, presence of
sedation at time of onset, initial treatment of PHM and
clinical outcome were obtained from patients’ medical
records. Clinical outcome was assessed one year after
CPR and expressed in Cerebral Performance Category
(CPC, range 1–5).24 In patients who had died, cause of
death was determined. In case treatment was withdrawn,
it was verified whether this was due to a neurological or
nonneurological reason.
Clinical assessment
Clinical characteristics of PHM were assessed using frag-
ments of video. In each patient 3 min of video was
selected, including myoclonic jerks and a pain and audi-
tory stimulus. The videos were evaluated by three neurol-
ogists (BMJ, JN, RZ) with expertise in neurocritical care
and movement disorders. Raters were blinded for clinical
outcome, and classified the following PHM characteristics:
clinical subtype (generalized or focal, unifocal/multifocal),
localization (proximal or distal), stimulus sensitivity (pre-
sent or absent) and severity of PHM.10 Myoclonus solely
present in the face was evaluated as “distal” localized, due
to the large representation of the (oral area of the) face in
the motor homunculus.25 PHM severity was assessed with
the Clinical Global Impression of Severity scale (CGI-S)
(range 1–7)26 and the 2nd part of the Unified Myoclonus
Rating Scale (UMRS).27 The latter quantifies myoclonus
severity in resting state by multiplying the amplitude and
frequency of PHM in eight different body parts (range 0–
128). The higher the CGI-S and UMRS scores, the more
severe the myoclonus is. PHM characteristics were classi-
fied based on the score of two or three similar ratings.
The CGI-S and UMRS scores were averaged.
Clinical neurophysiology
The EEG-EMG was recorded using BrainRT software
(OSG BVBA, Rumst, Belgium). In 12 patients a sample
rate of 1000 Hz was used and in seven 250 Hz. EEG
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electrodes were placed according to the International 10–
20 system (19 scalp electrodes; Fz referenced, impedance
<10 kO). EMG was performed with bipolar referenced
Ag/AgCl surface electrodes (impedance: <50 kO) located
3 cm adjacent to each other on the muscle. The number
of EMG channels varied from four to nine. In eight
patients a standardized 9-channel EMG protocol was
used, which consisted of measurements at the following
muscles: masseter, orbicularis oculi, sternocleidomastoid,
biceps brachii, abductor pollicis brevis, rectus abdominis,
rectus femoris, tibialis anterior, and a muscle of choice
with myoclonus. EMG channels were placed at one side
of the body, a restriction that did not hold for the muscle
of choice. In the other 11 patients without standardized
EMG protocol, a more targeted muscle selection approach
was used in which muscles with myoclonus were chosen
(6-channel EMG, three patients; 4-channel EMG, seven
patients). In case multiple EEG-EMGs were performed,
the first recording with myoclonus was used. EEG-EMGs
were performed a median value of (M) 1 day (IQR 1)
after first appearance of PHM. The duration of the
recordings was (M) 38 min (range 10–120 min).
EEG background patterns were categorized as (1) iso-
electric, (2) low voltage, (3) burst suppression, (4) gener-
alized status epilepticus, (5) diffuse slowing, and (6) mild
encephalopathic or normal.6,28 EEGs were visually
inspected for motor cortex potentials before the onset
and in direct relation with PHM (Fig. 1A). If present,
mean duration of the motor cortex potential before the
onset of the myoclonic jerk was assessed using 10 ran-
domly assessed events.
Somatosensory-evoked potentials
Somatosensory-evoked potentials (SSEP) were obtained
by median nerve stimulation and considered absent if the
cortical N20 response was bilaterally absent (specific for
poor neurologic outcome in PAE).29 SSEP results were
derived from the database of the Department of Clinical
Neurophysiology.
Jerk-locked back averaging
JLBA was performed with BrainVision Analyzer 2 (Brain
Products GmbH, Gilching, Germany). Drift and move-
ment artifacts were removed using a Butterworth high-
pass filter (48 dB/octave) of 2 Hz (EEG) and 10 Hz
(EMG). EEG signals were re-referenced to a Hjorth (local
average) montage, and artifacts directly after and related
to PHM were accepted (since only EEG prior to PHM
was evaluated). PHM bursts on EMG were selected with
markers placed consistently at EMG onset. To prevent
muscle artifact contamination from previous myoclonic
jerks, only EMG bursts were included with an interval to
the prior burst longer than 80 msec (M 250 msec, range
80–2000). The averaged EEG (M 127, range 30–675) was
evaluated in a window starting 300 msec before and
100 msec after PHM onset. Reproducibility of JLBA
results was checked using odd/even averaging.21 In “syn-
chronous” jerks with multiple muscle involvement, the
first contracting muscle was used for further analyses. In
“nonsynchronous” jerks, the EMG-channel with most
prominent myoclonus was selected. Additionally, an
EMG-channel with second most prominent myoclonus
(not involved in an “synchronous” jerk) was examined as
well in order to evaluate whether CM and SM might co-
occur in PHM. JLBA was considered positive (CM pre-
sumed) if a replicable potential was present at the con-
tralateral motor cortex 10–40 msec preceding the
myoclonic jerk, and if absent SM was suspected
(Fig. 1B).11,21
Coherence analysis
Coherence analysis was performed using in-house written
software build in LabVIEW (National Instruments 2014,
Austin, Texas, United States) based on the description of
Halliday and colleagues (1995).23 The same EEG-EMG fil-
ter and re-referencing method used for JLBA were
applied. Additionally, the EMG channels were rectified to
enhance the firing rate information of the signal.30 The
EEG-EMG was segmented into nonoverlapping epochs of
1-second based on the position of the JLBA markers. A
Fourier transformation of the epochs was performed
using a Hanning window and averaged (M 84 averages,
range 29–249) to obtain the frequency autospectra of
motor cortex EEG and contralateral EMG. Coherence
(range 0–1) was calculated and considered significant if
exceeding the 95% confidence level at four or more con-
secutive 1 Hz bins. Phase lag and corticomuscular con-
duction time were assessed for the significant coherence
bins.23,31 CM was considered present (coherence positive)
if coherence was found between motor cortex and con-
tralateral myoclonus muscle with appropriate phase
(EMG follows EEG) and conduction time.23 SM was con-
cluded (coherence negative) if no corticomuscular coher-
ence, or corticomuscular coherence with inappropriate
phase (EEG follows EMG) was present (Fig. 1C).
Neurophysiological classification
To classify the anatomical origin of PHM, five different
neurophysiological methods were used, namely: (1) visual
inspection of EEG, (2) EMG burst-duration, (3) muscle
recruitment order, (4) JLBA, and (5) coherence analy-
sis.6,9–11,18–22 Cortical PHM was presumed if (1) an EEG
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spike prior PHM was visible on EEG, (2) a mean burst
duration <75 msec was present (10 randomly assessed
jerks), (3) a cranio-caudal muscle recruitment order or
only single myoclonic jerk(s) were present, (4) JLBA was
positive, or (5) reliable corticomuscular coherence was
present. On the contrary, subcortical PHM was suspected
if the aforementioned criteria were absent, and/or a
“lower-brainstem first” recruitment pattern was present
(Table 1).
Methods i, ii and iii were considered as basic neuro-
physiological methods. Two or three identical findings
considering PHM origin determined the overall conclu-
sion of basic neurophysiology (i.e. cortical or subcortical
PHM). Advanced neurophysiology consisted of JLBA and
Figure 1. A posthypoxic myoclonus patient with generalized jerks from cortical origin. (A) The EEG shows spiking activity before onset of the
EMG bursts of the generalized jerk, and on EMG a cranio-caudal recruitment order is present with on average a burst duration of 90 msec
(EMG-channel 6). (B) Jerk-Locked Back Averaging of the right abdominis muscle (EMG-channel 6, 30 segments) with a clear motor cortex EEG
potential before the onset of muscle activation. (C) Corticomuscular coherence of Cz (Hjorth-montage) versus right abdominis muscle (EMG-
channel 6) with correct phase lag (EMG follows EEG signal) and reliable conduction velocity (24 msec). A (EEG spikes), B and C affirm a cortical
origin of the myoclonus (PHM case 5, Table 2).
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coherence analysis (iv-v). If both techniques were in line,
an overall conclusion for advanced neurophysiology could
be obtained.
Statistical analysis
Clinical characteristics and neurophysiological findings of
PHM were classified into (1) generalized/focal, (2)
SSEPN20 present/absent, (3) JLBA positive/negative and
(4) coherence positive/negative. Differences were
described and tested using a one-sided Mann-Whitney U-
test for numerical data, and a one-sided Fisher’s exact test
for binary data. In case a parameter could only be derived
from a selected number of patients, statistical analyses
were conducted only in the patients in whom the param-
eter was described. P-values < 0.05 were considered statis-
tical significant. To assess agreement among clinical,
basic, and advanced neurophysiological analyses of PHM,
Cohen and Fleiss kappa was used. Kappa results were
classified as; k < 0 “poor,” 0–0.2 “slight,” 0.21–0.4 “fair,”




Twenty PHM patients were included, but one was
excluded for further analyses as no EMG discharges were
found in relation to the myoclonic jerks. Mean age at
ICU admission was 56 (range 21–86) and 13 were male
(68%). Cardiac arrest occurred out-of-hospital in 14
patients (74%). In six patients (32%) PHM appeared
while sedation was still applied. In two patients (11%)
(mild) sedation was continued during the recording, since
otherwise the severity of myoclonus would have nega-
tively influenced mechanical ventilation. PHM was treated
with either single or combined medication in 17 patients
(89%) (sodium valproate 71%, propofol 47%,
clonazepam 24%, levetiracetam 12%, phenytoin 6%).
Two patients (11%) survived with mild to no cognitive
deficits, the other 17 died. One patient had recurrent car-
diac arrest during ICU admission and cardiac output
could not be restored. In the other 16 patients (94%),
neurological prognosis was considered poor. Mean time
to treatment withdrawal in the deceased patients was
5 days (range 2–10). Detailed patient characteristics are
provided in Table 2.
Clinical assessment
PHM was evaluated as generalized in seven (37%) and
focal in 12 (63%) patients. In 10 patients (53%) the prox-
imal muscle involvement was rated as more prominent
than in distal muscles. Auditory and pain stimuli were
assessed in 17 patients. None of the auditory stimuli had
an effect on PHM, however, pain stimuli-evoked myoclo-
nic jerks in 6/17 cases (35%). PHM severity was on aver-
age 3.8 (SD 1.3) CGI-S and M 14 (IQR 26) UMRS. In
generalized PHM, 6/7 cases (86%) had more pronounced
proximal muscle involvement, 2/7 (29%) were sensitive to
pain stimuli and severity was on average 5.0 (SD 0.7)
CGI-S and M 33 (IQR 20) UMRS. In contrast, focal
PHM was localized more distally in 4/12 cases (33%),
sensitivity to pain in 4/10 (40%) cases and its severity
was on average 3.1 (SD 1.1) CGI-S and M 9.7 (IQR 11)
UMRS. In generalized PHM, significantly more proximal
(P = 0.04) and severe (CGI-S; P = 0.004, UMRS;
P = 0.001) myoclonic jerks were present compared to
focal PHM. Time to PHM onset and initial rhythm did
not differ statistically between generalized and focal PHM
(Table 3).
Electroencephalography
The distribution of EEG background patterns is depicted
in Table 2. Four patients (21%) had a spike in EEG prior
PHM onset, and the potentials started M 40 msec (range
17–124) before the myoclonic jerk. The occurrence of sta-
tus epilepticus and EEG spikes prior to myoclonic bursts
did not differ significantly between generalized and focal
PHM (Table 3).
Electromyography
EMG burst duration was M 55 msec (range 36–130), in
which 15 patients (79%) had a burst duration below
75 msec (Table 2). Muscle recruitment of PHM started in
the lower brainstem with up- and downstream muscle
activation in two cases (11%). In the other patients, three
showed myoclonus following a cranio-caudal recruitment
Table 1. Neurophysiological criteria cortical and subcortical posthy-
poxic myoclonus.
Method Cortical PHM Subcortical PHM
Visual inspection
of EEG
EEG spike before jerk EEG spike not present
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pattern (16%), five presented myoclonus only in a single
EMG-channel (26%), and nine had myoclonus in multi-
ple EMG-channels without a specific pattern (47%). Burst
duration and brainstem recruitment order did not differ
significantly between generalized and focal PHM
(Table 3).
Somatosensory-evoked potentials
In 12/19 PHM patients (63%) SSEP recordings were per-
formed. N20 responses were bilaterally absent in six
patients (50%), and the other six had an N20 response in
at least one hemisphere. In SSEPN20- patients, 1/6 (17%)
had generalized PHM, and SSEPN20+ 4/6 (67%) focal
PHM (Table 3).
Jerk-locked back averaging
Analysis with JLBA showed presence of CM in 10/19
patients (53%) (Table 2). In generalized PHM, 6/7
patients (86%) had JLBA-proven CM, whereas focal PHM
exhibited 4/12 (33%) CM. This distribution of CM
among PHM subtypes was significantly different
(P = 0.04). An EEG spike(s) before onset of PHM was
present in 4/10 patients (40%) with positive JLBA. In case
JLBA was negative, no prejerk EEG spikes were seen
(P = 0.05). In addition, SSEPN20- patients did not show
CM with JLBA. Contrarily, in SSEPN20+ patients, signifi-
cantly more CM was found (4/6 patients, 67%)
(P = 0.03) (Table 3).
Coherence analyses
Eight patients (42%) presented corticomuscular coherence
with appropriate phase lag (i.e. CM) (Table 2). In
patients with onset of PHM <24 h after CPR SM was
found in 9/11 cases (81%). If PHM occurred >24 h after
CPR, SM was only present in 2/8 cases (25%), which was
significantly different (P = 0.02). Coherence analysis iden-
tified CM in 6/7 (86%) generalized PHM patients (86%),
whereas focal PHM patients showed significantly less CM
(4/12, 17%; P = 0.006). No prejerk EEG spikes were seen
in coherence negative (SM) patients, whereas such spikes
were seen in 4/8 (50%) patients with corticomuscular
coherence (CM) (P = 0.02). In SSEPN20- patients CM was
absent, whereas in SSEPN20+ CM was present in 4/6 cases
(67%) (P = 0.03). In all coherence positive patients, JLBA
showed CM as well. In the patients with no
Table 2. Characteristics of posthypoxic myoclonus patients.
# Cause ECG ROSC PHM Type UMRS CM signs SM signs EEG SSEP CPC
1 Cardiac VF 40 day 2 MF 3 S+ B+ R+ J+ C+ DS N/A 1
2 Cardiac VF N/A day 2 GZ 33 R+ J+ C+ S- B- SE N20+ 5
3 Cardiac Asys 75 day 1 MF 3 B+ S- R- J- C- DS N20- 5
4 Cardiac VF 29 day 1 MF 14 B+ R+ S- J- C- BS N20- 5
5 Cardiac VF N/A day 2 GZ 14 S+ R+ J+ C+ B- SE N/A 2
6 Cardiac VF N/A day 1 GZ 48 B+ R+ J+ C+ S- BS N20+ 5
7 Cardiac VF N/A day 5 MF 11 R+ S- B- J- C- LV N20+ 5
8 Cardiac VF N/A day 1 MF 3 B+ R+ J+ S- C- SE N/A 5
9 Hypoxic PEA N/A day 1 GZ 56 B+ R+ S- J- C- SE N20- 5
10 Hypoxic Asys N/A day 1 GZ 28 S+ B+ R+ J+ C+ DS N20+ 5
11 Hypoxic Asys 24 day 1 MF 20 R+ S- B- J- C- BS N20- 5
12 Hypoxic PEA N/A day 2 MF 4 B+ R+ S- J- C- SE N20- 5
13 Hypoxic VT 15 day 2 GZ 45 S+ B+ R+ J+ C+ BS N20+ 5
14 Hypoxic Asys 20 day 1 MF 8 B+ R+ S- J- C- BS N20- 5
15 Hypoxic Asys 55 day 2 GZ 31 B+ R+ J+ C+ S- DS N/A 5
16 Other PEA N/A day 3 MF 7 B+ R+ J+ C+ S- SE N/A 5
17 Other PEA 20 day 1 MF 12 B+ J+ S- R- C- BS N/A 5
18 Other PEA 10 day 1 MF 13 B+ R+ S- J- C- BS N/A 5
19 Other PEA N/A day 1 MF 38 B+ R+ S- J- C- SE N20+ 5
N Cardiac VF/VT t (m) (SD) <24 h GZ M (IQR) JLBA+ JLBA- LV/BS N20- CPC 1-2
19 8 (42%) 8 (42%) 32 (21) 11 (58%) 7 (37%) 14 (26) 10 (53%) 9 (47%) 8 (42%) 6 (50%) 2 (11%)
Asys, Asystole; B, burst duration; BS, burst-suppression; C, coherence analysis; CM, cortical myoclonus; CPC, cerebral performance category; DS,
diffuse slowing; ECG, electrocardiography initial rhythm; GZ, generalized PHM; IQR, Interquartile range; J, Jerk-locked Back Averaging (JLBA); LV,
low-voltage; MF, unifocal+multifocal PHM; Other=#16-septic shock #17-hyperkalemia #18-hemoptoe #19-air embolisms, PEA, pulseless electrical
activity, R, recruitment order; ROSC, return of spontaneous circulation (time in minutes after cardiac arrest); S, EEG spike; SD, standard deviation;
SE, generalized status epilepticus; SM, subcortical myoclonus; SSEP, somatosensory-evoked potentials; VF, ventricular fibrillation; VT, ventricular
tachycardia.
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corticomuscular coherence, 2/11 (18%) patients showed
CM with JLBA (Table 3).
Intermethod agreement
In only two patients (11%) the clinical interpretation,
basic- and advanced neurophysiological findings of
PHM origin were in line with one another. The agree-
ment between “clinic versus basic neurophysiology”
(j = 0.20, 95% CI = 0.59 to 0.19) and “clinic ver-
sus advanced neurophysiology” (j = 0.63, 95%
CI = 1.00 to 0.25) were poor. The “basic versus
advanced neurophysiology” comparison had fair agree-
ment (j = 0.20, 95% CI = 0.18 to 0.58) (Fig. 2). In
addition, JLBA and coherence analysis showed substan-
tial agreement (j = 0.79, 95% CI = 0.52 to 1.00),
whereas the other comparisons between the different
neurophysiological methods showed low intermethod
agreement (Table S1).
Co-occurrence of cortical and subcortical
posthypoxic myoclonus
Seven of 19 patients (37%) presented on EMG another
muscle with myoclonic jerks, who were not involved in a
“synchronous” jerk, secondary prominent, and suitable
for advanced neurophysiological assessment. Analyses
showed in 5/7 (71%) of these patients an identical
anatomical origin compared to the first examined EMG-
channel with (most prominent) myoclonic jerks. In the
other two patients, CM and SM co-occurred.
Outcome
Two patients (11%) survived. One patient exhibited clini-
cally focal PHM (Case 1, Table 2) and the other general-
ized PHM (Case 5, Table 2, Fig 1). Neurophysiological
analyses of the first patient revealed a diffuse slow EEG
pattern and an EEG spike 17 msec before the onset of
PHM. The muscle recruitment consisted of a single
twitching muscle with on average a burst duration of
54 msec. The other patient had a status epilepticus,
EEG spikes starting 120 msec before PHM onset, a cra-
nio-caudal muscle recruitment pattern, and an averaged
burst duration of 90 msec. JLBA and coherence analysis
showed CM in both patients. SSEPN20 responses were not
obtained for these patients.
Discussion
In this study we investigated the relation between the
clinical presentation and anatomical origin of PHM with
Table 3. Comparisons between subgroups of posthypoxic myoclonus patients.
Clinical assessment Advanced neurophysiology
GZ MF SSEP- SSEP+ JLBA- JLBA+ COH- COH+
Patients, n 7–12 6–6 9–10 11–8
Clinical assessment
Outcome, %survived 14–8% 0–0% 0–20% 0–20%
Cause CPR, %cardiac 43–42% 33–50% 33–50% 36–50%
Initial rhythm, %VF/VT 57–33% 17–67% 22–60% 27–63%
Onset PHM, %<24 h 43–67% 83–50% 78–40% 81–25%*
CGI-S, mean 5.0–3.1* 3.3–4.8 3.5–4.0 3.5–4.2
UMRS, median 36–12* 18–34 13–22 17–26
Localization, %proximal 86–33%* 50–80% 55–50% 45–63%
Stimulus sensitive, %yes 29–40%n=10 33–33% 33–38%n=8 40n=10–29%n=7
PHM type, %GZ n/a–n/a 17–67% 11–60%* 9–75%*
Basic neurophysiology
EEG pattern, %SE 43–33% 33–33% 33–40% 36–38%
EEG spike, %yes 43–8% 0–33% 0–40% 0–50%*
EMG bursts, %<75 msec 71–83% 83–67% 78–80% 82–75%
Recruitment, %brainstem 0–17% 17–0% 13–11% 18–0%
Advanced neurophysiology
SSEP, %N20- 20n=5–71%n=7 n/a–n/a 75n=8–0%n=4* 75n=8–0%n=4*
JLBA, %+ (CM) 86–33%* 0–67%* n/a–n/a 18–100%*
Coherence, %+ (CM) 86–17%* 0–67%* 0–80%* n/a–n/a
COH, coherence; “+” present, “-” absent; CM, cortical myoclonus; CPR, cardiopulmonary resuscitation; CGI-S, Clinical Global Impression of Sever-
ity scale; GZ, generalized PHM; JLBA, Jerked-Locked Back Averaging; “+” cortical potential present, “-” potential absent, MF, unifocal+multifocal
PHM; SE, status epilepticus; SSEP, Somatosensory-evoked potentials; “+” N20 response present, “-” N20 bilaterally absent, UMRS, Unified Myo-
clonus Rating Scale (2nd part); VF/VT, ventricular fibrillation/tachycardia; * = P < 0.05.
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use of comprehensive EEG-EMG-video recording in a
cohort of 19 patients. The main finding was that the clin-
ical interpretation of PHM origin poorly matched with
the origin based on the neurophysiological investigations.
The agreement between “clinical presumed” and “neuro-
physiological obtained” cortical or subcortical PHM was
poor. In addition, CM was more likely present in general-
ized PHM compared to focal PHM.
Clinical versus neurophysiological findings
of posthypoxic myoclonus
The presumed anatomical origin of PHM based on the
clinical presentation of myoclonus had poor agreement
with the neurophysiologically determined origin of PHM
(Fig. 2). PHM case 5, illustrated in Figure 1, is an exam-
ple of a patient in which clinically a subcortical origin
was suspected (generalized myoclonus) and a cortical ori-
gin was found with JLBA and coherence analysis. Most
importantly, this patient survived with only mild cogni-
tive deficits. Moreover, in this cohort CM was more likely
present in patients with generalized PHM than in focal
PHM. This result is in line with earlier studies who
demonstrated that generalized PHM can arise from the
cortex.5,6,33 These findings suggest that the clinical model
of typical CM and SM phenomenology that physicians
encounter in noncomatose myoclonus patients at the out-
patient clinic does not apply for PHM in the first few
days after resuscitation.10,11 In addition, the aforestated
emphasizes that the acute stage of PAE with PHM is
unique and different from the late type of PHM (Lance
Adams) and reticular reflex myoclonus that can be found
in “chronic” survivors.
Pathophysiology of cortical generalized
posthypoxic myoclonus
Cortical generalized myoclonus was repeatedly found in
the current cohort of PHM patients. In contrast, in the
general outpatient clinic population, patients with cortical
generalized myoclonus are uncommon.10 This discrepancy
might be caused by the presence of variable anoxic/
Figure 2. Agreement between the clinical, basic and advanced neurophysiological assessment of posthypoxic myoclonus origin. (A) Kappa scores
with 95% confidence intervals between the clinical interpretation of PHM origin (generalized = subcortical, focal (unifocal and multifocal) =
cortical) and the basic (B-NPhys) or advanced neurophysiological (A-NPhys) assessment of PHM origin. (B) Percentage agreement between the
aforementioned modalities.
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hypoxic damage to the architecture of brain motor path-
ways in PHM patients. This damage may pave the way
for a variety of mechanisms in which cortical generalized
PHM can occur.3,7,33 For example, in some cases, a gener-
alized jerk could arise from seizures wherein generalized
ictal discharges act as the cortical source of PHM.33,34
Another explanation for cortical-produced generalized
myoclonus is that a focal discharge in the cortex spreads
and activates the ipsilateral motor cortex (intrahemi-
spheric excitation spread). However, meanwhile, via the
corpus callosum the contralateral motor cortex is acti-
vated as well (interhemispheric excitation spread), finally
effectively producing a bilateral generalized jerk.33–35 Cer-
tainly, generalized PHM can arise from the brainstem.8
However, it is not clear if in every case damage to the
brainstem is causative for its manifestation. Brainstem
PHM might in some cases be a result of hypoxic/anoxic
cortex damage, in which the latter is unable to generate
inhibitory activity on spontaneous brainstem discharges.34
In addition, CM and SM may co-occur in PHM (present
study 11%),35 which in conjunction with the above illus-
trates the complexity of this movement disorder.
Posthypoxic myoclonus as outcome
predictor in postanoxic encephalopathy
Generalized PHM has been correlated with poor outcome
in PAE and included as prognosticator of poor outcome in
the American postanoxic coma guideline.1,3 It is thought
that the CM or SM represents the localization of anoxic
brain decay in PHM patients.8,33–35 The general hypothesis
is that damage to the brainstem is worse in terms of prog-
nosis compared to cortical lesions in PAE.1,7 Generalized
myoclonus has been associated with a subcortical origin,7–
11 however in this study we showed that generalized PHM
can be of cortical origin as well. Interestingly, Gentsch and
colleagues (2015) found that the total amount of brain
damage predicts outcome in PAE.36 This finding suggests
that patients with a multiple lesioned cortex (and CM)
could have a worse outcome compared to patients with a
singular, small brainstem lesion (and SM). In addition,
studies that correlated the generalized and focal PHM phe-
notype to outcome found that the severity of myoclonus,
and not per se the presence or absence of brainstem dam-
age, was related to poor outcome.1,5,6 Yet in contrast,
another finding of this study was that in patients presenting
PHM within 24 h after CPR, significantly less CM occurred
(Table 3). This may indicate that the presence of SM is
related to poor outcome, since early appearance of PHM
has been correlated to poor outcome in various stud-
ies.3,6,17 Moreover, the two patients that survived had CM,
which suggests that the anatomical location or the presence
of corticomuscular coupling could be a predictor of good
outcome in PAE. However, in general there are no
sufficiently large sized studies correlating the exact anatom-
ical location of brain damage with PHM phenotype, origin
and outcome.
The above considerations suggest that the exact role of
PHM as PAE prognosticator has not been adequately
refined yet to play a pivotal role in treatment decisions to
withdraw life support. If the origin of PHM turns out to
be the key for outcome prognostication in PAE, JLBA
and coherence analysis can be used for a reliable assess-
ment. In addition, the specific PHM EEG background
patterns proposed by Elmer and colleagues (2016) may
have a role in the outcome prediction as well.37 In case
severity of PHM is the factor that predicts outcome, the
UMRS might be a suitable tool to use.16,27 It may be pos-
sible to add the aforementioned factors into a multi-
model algorithm that results in one prognostic score for
PAE.12,38 An example of this is the recently introduced
Cerebral Recovery Index.39
Limitations
A limitation of this study was the absence of a gold stan-
dard in identifying PHM origin. Moreover, the sensitivity
and specificity of the neurophysiological methods used
are unknown (except for SSEP as prognosticator in PAE).
On the other hand, JLBA and coherence analysis have
proven their role in clinical practice in evaluating
anatomical origin of myoclonus and can therefore be seen
as a reliable marker.11,18,20–22,31 Indeed, the agreement
between JLBA and coherence analysis turned out to be
substantial: 17/19 patients had identical findings. Further-
more, in SSEPN20- patients CM was absent with JLBA and
coherence analysis. This result speaks in favor of the relia-
bility of these techniques, despite that SSEP and JLBA/co-
herence are indirect related to each other.11,29
Another limitation was that the sample size of this
study was too small to prove a direct relation between the
occurrence of CM in PHM patients and outcome. More-
over, the study consisted of prospective and retrospective
included patients. However, a bias is unlikely since the
distribution of generalized and focal PHM did not differ
between the prospective and retrospective group.
A different source of uncertainty in this study was that
the clinical assessment of PHM might have been challeng-
ing due to the dynamic and intermittent character of
PHM and the use of video recordings leading to an
observation that is less vivid.13,14,16 To circumvent this
issue, three instead of one experienced neurologist inter-
preted the clinical videos. In addition, video recording
with simultaneous EEG-EMG ensures that the same jerks
were assessed by both the physicians and the clinical neu-
rophysiological analyses, which is an advantage.
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Conclusion
In summary, the main finding of this study was that
the clinical presumed anatomical origin of PHM poorly
matched the result obtained with neurophysiology. It is
possible that hypoxic damage to variable cortical and
subcortical areas in the brain lead to mixed and vary-
ing clinical manifestations of myoclonus that differ of
those patients with myoclonus generally encountered in
the outpatient clinic. The current clinical classification
of PHM is not adequately refined to play a pivotal role
in guiding treatment decisions to withdraw care. To
further explore the potential role of PHM as prognosti-
cator in PAE, comprehensive studies combining clinical,
neurophysiological, imaging, and pathological data are
needed.
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